Lupin US market growth – The Milli Chronicle

Thursday, November 6, 2025

Latest:

India’s Services Sector Maintains Strong Momentum Despite Seasonal Slowdown in October
India Aims to Build Global-Scale Banks Through Strategic Mergers and Financial Reforms
Lupin Reports Impressive Profit Surge Driven by Strong Demand for Respiratory Drugs
India’s LIC Reports Strong Profit Growth and Optimistic Outlook for Second Half
Singtel to Unlock Value Through Strategic Stake Sale in Bharti Airtel

Factual Version of a Story

Asia Featured Latest

NewsDesk Milli Chronicle November 6, 2025November 6, 2025 biosimilars India, India pharma exports, Indian drugmakers global market, Indian healthcare growth, Indian pharmaceutical industry, Lupin earnings report, Lupin financial results 2025, Lupin innovation, Lupin net profit increase, Lupin pharmaceutical news, Lupin quarterly profit, Lupin research and development, Lupin respiratory drugs, Lupin revenue surge, Lupin stock performance, Lupin US market growth, Nirmal Yadav Lupin

Lupin Reports Impressive Profit Surge Driven by Strong Demand for Respiratory Drugs

Lupin records a major leap in quarterly profits, powered by strong global demand for its respiratory medicines and continued expansion